Key points are not available for this paper at this time.
Over the last decade, transplantation of circulating autologous hematopoietic stem cells to facilitate the recovery of bone marrow (BM) function following administration of marrow ablative anti-cancer therapy has been used with increasing frequency. During that time, a number of indications for peripheral stem cell transplantation (PSCT) emerged
Kessinger et al. (Tue,) studied this question.